타디브 디스키네시아 치료 시장 점유율 분석 및 기회 [2025-2031]
Tardive Dyskinesia Treatment Market Report Analysis
Tardive Dyskinesia Treatment Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Teva Pharmaceutical Industries Ltd
- Neurocrine Biosciences, Inc
- Sun Pharmaceutical Industries Ltd
- SteriMax Inc.
- Adamas Pharmaceuticals, Inc
- Sanis
- AbbVie Inc.
- Mylan N.V,
- Reddyâs Laboratories Ltd,
Regional Overview
- 북미
- 유럽
- 아시아 태평양
- 중남미
- 중동 및 아프리카
Market Segmentation
By 장애
- 운동완서증
- 운동과다증
By 약물 종류
- 도파민 고갈 약물
- VMAT2 억제제
- GABA 수용체 작용제 약물
- 항콜린성 약물 트리헥시페니딜
By 최종 사용자
- 병원
- 임상
- 기타
By 지리
- 북미
- 유럽
- 아시아 태평양
- 중남미
Get Free Sample For